Marijuana Abuse
46
2
2
37
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
12 trials with published results (26%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.3%
2 terminated out of 46 trials
94.9%
+8.3% vs benchmark
7%
3 trials in Phase 3/4
32%
12 of 37 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 37 completed trials
Clinical Trials (46)
Applying Mixed Methods to Identify Links Between PTSD Symptoms, Cannabis Use, and Functional Behaviors With Personalized Feedback Intervention Development
Neuroimaging of Adolescent Cannabis Use Treatment
The Effect of Food on the Oral Bioavailability of AEF0117 in Healthy Volunteers
Cohort Study on Medical Students' Mental Health
Detecting Drugs of Abuse Via Exhaled Breath Samples Using Differential Mobility Spectrometry
Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)
Substance Use Interventions for Truant Adolescents
Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users
Effects of Stress and Drug-cue Exposure (SCM)
Study of [4-14C] AEF0117 Following a Single Oral Dose in Healthy Male Subjects
Short-Term Exposure for PTSD
Effects of Cannabidiol on Marijuana-seeking in Humans
Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects
Therapeutic Substance Abuse Treatment in Pregnancy - 1
Mobile Contingency Management for Marijuana and Tobacco Cessation
CBT-I for Cannabis Use
Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1
Dronabinol Treatment for Marijuana Addiction
Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder
Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults